Search

Your search keyword '"Goodwin, Guy"' showing total 992 results
Start Over Author "Goodwin, Guy" Publication Type Academic Journals
992 results on '"Goodwin, Guy"'

1. The True Colours Remote Symptom Monitoring System: A Decade of Evolution

Author

Goodday, Sarah M, Atkinson, Lauren, Goodwin, Guy, Saunders, Kate, South, Matthew, Mackay, Clare, Denis, Mike, Hinds, Chris, Attenburrow, Mary-Jane, Davies, Jim, Welch, James, Stevens, William, Mansfield, Karen, Suvilehto, Juulia, and Geddes, John

Subjects
Computer applications to medicine. Medical informatics, R858-859.7, Public aspects of medicine, RA1-1270
Abstract

The True Colours remote mood monitoring system was developed over a decade ago by researchers, psychiatrists, and software engineers at the University of Oxford to allow patients to report on a range of symptoms via text messages, Web interfaces, or mobile phone apps. The system has evolved to encompass a wide range of measures, including psychiatric symptoms, quality of life, and medication. Patients are prompted to provide data according to an agreed personal schedule: weekly, daily, or at specific times during the day. The system has been applied across a number of different populations, for the reporting of mood, anxiety, substance use, eating and personality disorders, psychosis, self-harm, and inflammatory bowel disease, and it has shown good compliance. Over the past decade, there have been over 36,000 registered True Colours patients and participants in the United Kingdom, with more than 20 deployments of the system supporting clinical service and research delivery. The system has been adopted for routine clinical care in mental health services, supporting more than 3000 adult patients in secondary care, and 27,263 adolescent patients are currently registered within Oxfordshire and Buckinghamshire. The system has also proven to be an invaluable scientific resource as a platform for research into mood instability and as an electronic outcome measure in randomized controlled trials. This paper aimed to report on the existing applications of the system, setting out lessons learned, and to discuss the implications for tailored symptom monitoring, as well as the barriers to implementation at a larger scale.

Published
2020
Full Text
View/download PDF

2. Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?

Author

Pasculli, Giuseppe, Busan, Pierpaolo, Jackson, Eric, Alm, Per, De Gregorio, Danilo, Maguire, Gerald, Goodwin, Guy, Gobbi, Gabriella, Erritzoe, David, and Carhart-Harris, Robin

Subjects
default mode network, developmental stuttering, neuropsychopharmacology, psychedelic compounds, social-cognitive networks
Abstract

Developmental stuttering (DS) is a neurodevelopmental speech-motor disorder characterized by symptoms such as blocks, repetitions, and prolongations. Persistent DS often has a significant negative impact on quality of life, and interventions for it have limited efficacy. Herein, we briefly review existing research on the neurophysiological underpinnings of DS -specifically, brain metabolic and default mode/social-cognitive networks (DMN/SCN) anomalies- arguing that psychedelic compounds might be considered and investigated (e.g., in randomized clinical trials) for treatment of DS. The neural background of DS is likely to be heterogeneous, and some contribution from genetically determinants of metabolic deficiencies in the basal ganglia and speech-motor cortical regions are thought to play a role in appearance of DS symptoms, which possibly results in a cascade of events contributing to impairments in speech-motor execution. In persistent DS, the difficulties of speech are often linked to a series of associated aspects such as social anxiety and social avoidance. In this context, the SCN and DMN (also influencing a series of fronto-parietal, somato-motor, and attentional networks) may have a role in worsening dysfluencies. Interestingly, brain metabolism and SCN/DMN connectivity can be modified by psychedelics, which have been shown to improve clinical evidence of some psychiatric conditions (e.g., depression, post-traumatic stress disorder, etc.) associated with psychological constructs such as rumination and social anxiety, which also tend to be present in persistent DS. To date, while there have been no controlled trials on the effects of psychedelics in DS, anecdotal evidence suggests that these agents may have beneficial effects on stuttering and its associated characteristics. We suggest that psychedelics warrant investigation in DS.

Published
2024

3. The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression

Author

Goodwin, Guy M., Aaronson, Scott T., Alvarez, Oscar, Carhart-Harris, Robin, Chai-Rees, Jamie, Croal, Megan, DeBattista, Charles, Dunlop, Boadie W., Feifel, David, Hellerstein, David J., Husain, Muhammad I., Kelly, John R., Kirlic, Namik, Licht, Rasmus W., Marwood, Lindsey, Meyer, Thomas D., Mistry, Sunil, Nowakowska, Ania, Páleníček, Tomáš, Repantis, Dimitris, Schoevers, Robert A., Simmons, Hollie, Somers, Metten, Teoh, Emma, Tsai, Joyce, Wahba, Mourad, Williams, Sam, Young, Allan H., Young, Matthew B., Zisook, Sidney, and Malievskaia, Ekaterina

Published
2025
Full Text
View/download PDF

7. A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression

Author

Jauhar, Sameer, Arnone, Danilo, Baldwin, David S., Bloomfield, Michael, Browning, Michael, Cleare, Anthony J., Corlett, Phillip, Deakin, J. F. William, Erritzoe, David, Fu, Cynthia, Fusar-Poli, Paolo, Goodwin, Guy M., Hayes, Joseph, Howard, Robert, Howes, Oliver D., Juruena, Mario F., Lam, Raymond W., Lawrie, Stephen M., McAllister-Williams, Hamish, Marwaha, Steven, Matuskey, David, McCutcheon, Robert A., Nutt, David J., Pariante, Carmine, Pillinger, Toby, Radhakrishnan, Rajiv, Rucker, James, Selvaraj, Sudhakar, Stokes, Paul, Upthegrove, Rachel, Yalin, Nefize, Yatham, Lakshmi, Young, Allan H., Zahn, Roland, and Cowen, Philip J.

Published
2023
Full Text
View/download PDF

13. Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial

Author

Landrø, Nils Inge, Harmer, Catherine J., Blackwell, Simon E., Bø, Ragnhild, Dawson, Gerry, Goodwin, Guy, Hagen, Hallvard Solbø, Kingslake, Jonathan, Klovning, Atle, Klungsøyr, Ole, Schjøtt-Pedersen, Olivia, Sæther, Anne Kjersti, Torgersen, Kristin Stensland, Vaaler, Arne, Andreassen, Ole A., and Røssberg, Jan Ivar

Published
2023
Full Text
View/download PDF

16. Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Author

Goodwin, Guy M., Aaronson, Scott T., Alvarez, Oscar, Atli, Merve, Bennett, James C., Croal, Megan, DeBattista, Charles, Dunlop, Boadie W., Feifel, David, Hellerstein, David J., Husain, Muhammad Ishrat, Kelly, John R., Lennard-Jones, Molly R., Licht, Rasmus W., Marwood, Lindsey, Mistry, Sunil, Páleníček, Tomáš, Redjep, Ozlem, Repantis, Dimitris, Schoevers, Robert A., Septimus, Batya, Simmons, Hollie J., Soares, Jair C., Somers, Metten, Stansfield, Susan C., Stuart, Jessica R., Tadley, Hannah H., Thiara, Nisha K., Tsai, Joyce, Wahba, Mourad, Williams, Sam, Winzer, Rachel I., Young, Allan H., Young, Matthew B., Zisook, Sid, and Malievskaia, Ekaterina

Published
2023
Full Text
View/download PDF

18. Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs

Author

Similon, Miriam von Mücke, Paasche, Cecilia, Krol, Fas, Lerer, Bernard, Goodwin, Guy M., Berk, Michael, Meyer-Lindenberg, Andreas, Ketter, Terence A., Yatham, Lakshmi N., Goldberg, Joseph F., Malhi, Gin S., El-Mallakh, Rif, Licht, Rasmus W., Young, Allan H., Kapczinski, Flavio, Swartz, Marnina, Hagin, Michal, Torrent, Carla, Serretti, Alessandro, Yildiz, Ayşegül, Martínez-Arán, Anabel, Strejilevich, Sergio, Rybakowski, Janusz, Sani, Gabriele, Grunze, Heinz, Vázquez, Gustavo, Pinto, Ana Gonzales, Azorin, Jean Michel, Nolen, Willem, Sentissi, Othman, López-Jaramillo, Carlos, Frey, Benicio N., Nierenberg, Andrew, Parker, Gordon, Bond, David J, Cohen, Adam, Tortorella, Alfonso, Perugi, Giulio, Vieta, Eduard, and Popovic, Dina

Published
2022
Full Text
View/download PDF

19. Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.

Author

Kirlić, Namik, Lennard-Jones, Molly, Atli, Merve, Malievskaia, Ekaterina, Modlin, Nadav L., Peck, Stephanie Knatz, Gaillard, Alice, Goodwin, Guy M., and Koelpin, Don

Subjects
MENTAL health services, PSILOCYBIN, MENTAL depression, PSYCHOTHERAPY, CLINICAL trials
Abstract

The psychedelic experience can be challenging. There is a need for a structured framework for providing psychological support to individuals with mental health conditions receiving investigational psilocybin treatment. The primary benefit of such a framework is to support a safe and meaningful psilocybin experience. It also enables future research on the facets of psychological support and/or psychotherapy that most optimally complement psilocybin treatment. The authors describe the Compass Psychological Support Model (CPSM), currently used to support participants with treatment-resistant depression in Compass-sponsored clinical trials of investigational COMP360 psilocybin treatment. The authors also outline the therapist training, mentoring, and fidelity assessment programs they have developed to ensure the quality and consistency of the CPSM delivery. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

20. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

Author

Reininghaus, Eva Z, Manchia, Mirko, Dalkner, Nina, Bonkat, Nina, Squassina, Alessio, Hodl, Isabel, Vieta, Eduard, Reif, Andreas, Hajek, Tomas, Landén, Mikael, Correll, Christoph U, Scott, Jan, Etain, Bruno, Rietschel, Marcella, Bergink, Veerle, Martinez-Cengotitabengoa, Monica, Kessing, Lars Vedel, Fagiolini, Andrea, Bauer, Michael, Goodwin, Guy, Gonzalez-Pinto, Ana, Kupka, Ralph W, Schulze, Thomas G, Lagerberg, Trine V, Yildiz, Ayşegül, Henry, Chantal, Morken, Gunnar, Ritter, Phillip, Nieslen, René Ernst, Licht, Rasmus W, Bechdolf, Andreas, Andreassen, Ole A, and Fellendorf, Frederike Tabea

Published
2022
Full Text
View/download PDF

23. DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network

Author

Kessing, Lars Vedel, González-Pinto, Ana, Fagiolini, Andrea, Bechdolf, Andreas, Reif, Andreas, Yildiz, Ayşegül, Etain, Bruno, Henry, Chantal, Severus, Emanuel, Reininghaus, Eva Z., Morken, Gunnar, Goodwin, Guy M., Scott, Jan, Geddes, John R., Rietschel, Marcella, Landén, Mikael, Manchia, Mirko, Bauer, Michael, Martinez-Cengotitabengoa, Monica, Andreassen, Ole A., Ritter, Philipp, Kupka, Ralph, Licht, Rasmus W., Nielsen, René Ernst, Schulze, Thomas G., Hajek, Tomas, Lagerberg, Trine Vik, Bergink, Veerle, and Vieta, Eduard

Published
2021
Full Text
View/download PDF

24. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Author

Carhart-Harris, Robin L and Goodwin, Guy M

Subjects
Mental Health, Brain Disorders, Depression, Mental health, Good Health and Well Being, Animals, Hallucinogens, History, 20th Century, History, 21st Century, Humans, Mental Disorders, Psilocybin, Medical and Health Sciences, Psychology and Cognitive Sciences, Psychiatry
Abstract

Plant-based psychedelics, such as psilocybin, have an ancient history of medicinal use. After the first English language report on LSD in 1950, psychedelics enjoyed a short-lived relationship with psychology and psychiatry. Used most notably as aids to psychotherapy for the treatment of mood disorders and alcohol dependence, drugs such as LSD showed initial therapeutic promise before prohibitive legislature in the mid-1960s effectively ended all major psychedelic research programs. Since the early 1990s, there has been a steady revival of human psychedelic research: last year saw reports on the first modern brain imaging study with LSD and three separate clinical trials of psilocybin for depressive symptoms. In this circumspective piece, RLC-H and GMG share their opinions on the promises and pitfalls of renewed psychedelic research, with a focus on the development of psilocybin as a treatment for depression.

Published
2017

29. The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial

Author

Browning, Michael, Bilderbeck, Amy C., Dias, Rebecca, Dourish, Colin T., Kingslake, Jonathan, Deckert, Jürgen, Goodwin, Guy M., Gorwood, Philip, Guo, Boliang, Harmer, Catherine J., Morriss, Richard, Reif, Andreas, Ruhe, Henricus G., van Schaik, Anneke, Simon, Judit, Sola, Victor Perez, Veltman, Dick J., Elices, Matilde, Lever, Anne G., Menke, Andreas, Scanferla, Elisabetta, Stäblein, Michael, and Dawson, Gerard R.

Published
2021
Full Text
View/download PDF

31. Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action

Author

Manchia, Mirko, Vieta, Eduard, Smeland, Olav B., Altimus, Cara, Bechdolf, Andreas, Bellivier, Frank, Bergink, Veerle, Fagiolini, Andrea, Geddes, John R., Hajek, Tomas, Henry, Chantal, Kupka, Ralph, Lagerberg, Trine V., Licht, Rasmus W., Martinez-Cengotitabengoa, Monica, Morken, Gunnar, Nielsen, René E., Pinto, Ana Gonzalez, Reif, Andreas, Rietschel, Marcella, Ritter, Phillip, Schulze, Thomas G., Scott, Jan, Severus, Emanuel, Yildiz, Aysegul, Kessing, Lars Vedel, Bauer, Michael, Goodwin, Guy M., and Andreassen, Ole A.

Published
2020
Full Text
View/download PDF

39. Thought Suppression in Patients With Bipolar Disorder

Author

Miklowitz, David J, Alatiq, Yousra, Geddes, John R, Goodwin, Guy M, and Williams, J Mark G

Subjects
Serious Mental Illness, Clinical Research, Behavioral and Social Science, Depression, Mental Health, Brain Disorders, Mental health, Adolescent, Adult, Affect, Aged, Analysis of Variance, Bipolar Disorder, Cognition, Female, Humans, Male, Middle Aged, Patient Selection, Repression, Psychology, Reward, Surveys and Questionnaires, Thinking, thought suppression, reward, hyperpositive thinking, mental control theory, cognitive biases
Abstract

Suppression of negative thoughts has been observed under experimental conditions among patients with major depressive disorder (MDD) but has never been examined among patients with bipolar disorder (BD). Patients with BD (n = 36), patients with MDD (n = 20), and healthy controls (n = 20) completed a task that required unscrambling 6-word strings into 5-word sentences, leaving out 1 word. The extra word allowed the sentences to be completed in a negative, neutral, or "hyperpositive" (manic/goal-oriented) way. Participants completed the sentences under conditions of cognitive load (rehearsing a 6-digit number), reward (a bell tone), load and reward, or neither load nor reward. We hypothesized that patients with BD would engage in more active suppression of negative and hyperpositive thoughts than would controls, as revealed by their unscrambling more word strings into negative or hyperpositive sentences. Under conditions of load or reward and in the absence of either load or reward, patients with BD unscrambled more negative sentences than did controls. Under conditions of reward, patients with BD unscrambled more negative sentences than did patients with MDD. Patients with BD also reported more use of negative thought suppression than did controls. These group differences in negative biases were no longer significant when current mood states were controlled. Finally, the groups did not differ in the proportion of hyperpositive sentence completions in any condition. Thought suppression may provide a critical locus for psychological interventions in BD.

Published
2010

41. The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis

Author

Freeman, Daniel, Sheaves, Bryony, Goodwin, Guy M, Yu, Ly-Mee, Nickless, Alecia, Harrison, Paul J, Emsley, Richard, Luik, Annemarie I, Foster, Russell G, Wadekar, Vanashree, Hinds, Christopher, Gumley, Andrew, Jones, Ray, Lightman, Stafford, Jones, Steve, Bentall, Richard, Kinderman, Peter, Rowse, Georgina, Brugha, Traolach, Blagrove, Mark, Gregory, Alice M, Fleming, Leanne, Walklet, Elaine, Glazebrook, Cris, Davies, E Bethan, Hollis, Chris, Haddock, Gillian, John, Bev, Coulson, Mark, Fowler, David, Pugh, Katherine, Cape, John, Moseley, Peter, Brown, Gary, Hughes, Claire, Obonsawin, Marc, Coker, Sian, Watkins, Edward, Schwannauer, Matthias, MacMahon, Kenneth, Siriwardena, A Niroshan, and Espie, Colin A

Published
2017
Full Text
View/download PDF

47. Internet use by patients with bipolar disorder: Results from an international multisite survey

Author

Bauer, Rita, Conell, Jörn, Glenn, Tasha, Alda, Martin, Ardau, Raffaella, Baune, Bernhard T., Berk, Michael, Bersudsky, Yuly, Bilderbeck, Amy, Bocchetta, Alberto, Bossini, Letizia, Castro, Angela M. Paredes, Cheung, Eric YW., Chillotti, Caterina, Choppin, Sabine, Del Zompo, Maria, Dias, Rodrigo, Dodd, Seetal, Duffy, Anne, Etain, Bruno, Fagiolini, Andrea, Hernandez, Miryam Fernández, Garnham, Julie, Geddes, John, Gildebro, Jonas, Gonzalez-Pinto, Ana, Goodwin, Guy M., Grof, Paul, Harima, Hirohiko, Hassel, Stefanie, Henry, Chantal, Hidalgo-Mazzei, Diego, Kapur, Vaisnvy, Kunigiri, Girish, Lafer, Beny, Larsen, Erik R., Lewitzka, Ute, Licht, Rasmus W., Lund, Anne Hvenegaard, Misiak, Blazej, Monteith, Scott, Munoz, Rodrigo, Nakanotani, Takako, Nielsen, René E, O’Donovan, Claire, Okamura, Yasushi, Osher, Yamima, Piotrowski, Patryk, Reif, Andreas, Ritter, Philipp, Rybakowski, Janusz K., Sagduyu, Kemal, Sawchuk, Brett, Schwartz, Elon, Scippa, Ângela M., Slaney, Claire, Sulaiman, Ahmad H., Suominen, Kirsi, Suwalska, Aleksandra, Tam, Peter, Tatebayashi, Yoshitaka, Tondo, Leonardo, Vieta, Eduard, Vinberg, Maj, Viswanath, Biju, Volkert, Julia, Zetin, Mark, Whybrow, Peter C., and Bauer, Michael

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results